Ad is loading...
MENU
APRE Aprea Therapeutics Forecast, Technical & Fundamental Analysis
a clinical-stage biopharmaceutical company
Industry Biotechnology
Show more...
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I. Advisor
published General Information
General Information
a clinical-stage biopharmaceutical company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
3805 Old Easton Road
Phone
+1 617 463-9385
Employees
7
Web
https://www.aprea.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BRBPX | 10.85 | N/A | N/A |
| Bridgeway Managed Volatility | |||
| MUIGX | 16.74 | -0.23 | -1.36% |
| Nationwide BNY Mellon Dyn US Core R6 | |||
| TAGDX | 15.35 | -0.22 | -1.41% |
| Transamerica Large Growth R6 | |||
| GSAHX | 15.78 | -0.30 | -1.87% |
| Goldman Sachs Small Cap Growth Investor | |||
| HGORX | 55.71 | -1.32 | -2.31% |
| Hartford Growth Opportunities R3 | |||
APRE and Stocks
Correlation & Price change
A.I.dvisor tells us that APRE and ATOS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APRE and ATOS's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To APRE | 1D Price Change % | ||
|---|---|---|---|---|
| APRE | 100% | -2.99% | ||
| ATOS - APRE | 32% Poorly correlated | -6.57% | ||
| BLPH - APRE | 30% Poorly correlated | N/A | ||
| NTLA - APRE | 28% Poorly correlated | -7.61% | ||
| MBRX - APRE | 27% Poorly correlated | -12.30% | ||
| STTK - APRE | 27% Poorly correlated | -9.85% | ||
More | ||||